Insights on Life Sciences

Headlines that Matter for Companies and Executives in Regulated Industries

Health care enforcement targeting diagnostic and laboratory services accelerated in 2025 and shows no signs of slowing down in 2026.

Headlines that Matter for Companies and Executives in Regulated Industries

Last month, the US District Court for the District of Columbia struck down a 2013 policy issued by the US Department of Health and Human Services Health Resources and Services Administration (HRSA) regarding the Section 340B Drug Pricing Program “GPO prohibition” and hospital replenishment (virtual inventory) practices.

Headlines that Matter for Companies and Executives in Regulated Industries

While Section 232 tariffs have so far been largely a metals-and-autos story, pharma has now officially joined the narrative.

Headlines that Matter for Companies and Executives in Regulated Industries

Michelle J. Shapiro to speak at Executive Women in Bio (EWIB) virtual program – Implementing Lessons Learned From Enforcement Developments to Improve Corporate Compliance.

Forget science fiction — the race to wire computers directly into the human brain is well underway, and it is moving fast.

Headlines that Matter for Companies and Executives in Regulated Industries

ArentFox Schiff, in collaboration with Consilio, will host the 2026 Chicago Pharma Forum on May 6, 2026, bringing together pharmaceutical industry leaders and in‑house counsel in the Chicago area for a full day of discussion and networking.

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

As we continue to move through 2026, the life sciences landscape is shaped by a convergence of regulatory, enforcement, and market access developments that demand heightened attention from industry stakeholders.

Headlines That Matter for Companies and Executives in Regulated Industries

Life Sciences Industry Group Co-Leader Stephanie Trunk will present on the evolving reimbursement policy landscape at the Healthcare Distribution Alliance’s (HDA) Distribution Management Conference and Expo on March 9, 2026.

The US Food and Drug Administration (FDA) issued a final rule on March 5 that will change National Drug Codes (NDCs) from several different 10‑digit formats to one standard 12‑digit format.

On February 19, the US Food and Drug Administration (FDA) announced a significant shift in its drug approval framework: A single adequate and well-controlled clinical trial, combined with confirmatory evidence, will now serve as the default standard for marketing authorization of new drugs.

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

Welcome to the February 2026 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and significant insights in an accessible format, concluding with our main takeaways — aka “And the Fox Says…” — on what you need to know.

ArentFox Schiff has released its latest annual report analyzing forced labor law developments and enforcement activity.

ArentFox Schiff is pleased to announce that five practice areas and 12 attorneys were recognized by Chambers Global 2026, including in the guide’s newly minted Global Market Leaders category.

While enforcement may have taken a backseat to other trade priorities in 2025, this year may be poised to bring a swift and aggressive return to form, particularly if the tariff landscape begins to stabilize.

Headlines that Matter for Companies and Executives in Regulated Industries